The fundraising comprises a rights issue for existing shareholders and a directed share issue to a select group of investors. The latter was subscribed to primarily by the EIC Fund and Cradle Growth, a relatively new Nordic growth equity and venture capital firm that has also invested in companies such as Suturion and Cuviva.
Inossia raises SEK 88m – targets US approval
The Swedish medtech company Inossia, which is developing an additive for bone cement, has completed an oversubscribed SEK 88 million share issue.
Advertisement